Back
BioNTech SE Quote, Financials, Valuation and Earnings
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
19
BNTX
BioNTech SE
Last Price:
89.21
Seasonality Move:
39.98%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.BioNTech SE Price Quote
$89.21
+2.00 (+2.29%)
(Updated: April 29, 2024 at 11:00 AM ET)
BioNTech SE Key Stats
Sell
19
BioNTech SE (BNTX)
is a Sell
Day range:
$86.89 - $88.32
52-week range:
$85.21 - $125.83
Dividend yield:
0%
P/E ratio:
21.03
P/S ratio:
5.11
P/B ratio:
0.93%
Volume:
348.3K
Avg. volume:
658.6K
1-year change:
-21.15%
Market cap:
$20.7B
Revenue:
$4.1B
EPS:
$4.11
How Much Does BioNTech SE Make?
-
How Much Are BioNTech SE's Sales Annually?
BNTX Revenues are $4.1B -
How Much Profit Does BioNTech SE's Make A Year?
BNTX net income is $1B
Is BioNTech SE Growing As A Company?
-
What Is BioNTech SE's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.64% -
What Is BioNTech SE's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.79%
BioNTech SE Stock Price Performance
-
Did BioNTech SE Stock Go Up Last Month?
BioNTech SE share price went down by -4.9% last month -
Did BNTX's Share Price Rise Over The Last Year?
BNTX share price fell by -21.15% over the past 1 year
What Is BioNTech SE 52-Week High & Low?
-
What Is BioNTech SE’s 52-Week High Share Price?
BioNTech SE has traded as high as $125.83 over the past 52 weeks -
What Is BioNTech SE’s 52-Week Low Share Price?
BioNTech SE has traded as low as $85.21 over the past 52 weeks
BioNTech SE Price To Free Cash Flow
-
Is BioNTech SE Stock Overvalued?
BioNTech SE is trading at a price to free cash flow ratio of 4.17 -
Is BioNTech SE Stock Undervalued?
BioNTech SE EV to Free Cash Flow ratio is 0.53 -
What Is BioNTech SE’s Price Earnings Growth Ratio?
BNTX PEG ratio is 0.00 -
Is BioNTech SE Trading At A Premium To Earnings?
BioNTech SE EV to EBIT ratio is 2.71
Is It Risky To Buy BioNTech SE?
-
How Much Debt Does BioNTech SE Have?
Total long term debt quarterly is $242.2M -
How Much Cash Does BioNTech SE Have?
Cash and short term investments quarterly total is $18.3B -
What Is BioNTech SE’s Book Value Per Share?
Book value per share is 94.14
Is BioNTech SE Cash Flow Positive?
-
What Is BNTX Cash Flow From Operations?
Cash flow from operations (TTM) is $5.8B -
What Is BioNTech SE’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$842.9M -
What Is BioNTech SE’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$7.5B
BioNTech SE Return On Invested Capital
-
Is Management Doing A Good Job?
BNTX return on invested capital is 4.55% -
What Is BioNTech SE Return On Assets?
ROA measures how assets are converting to revenues and is 4.09% -
What Is BNTX Return On Equity?
ROE is a measure of profitability and is 4.6%
BioNTech SE Earnings Date & Stock Price
-
What Is BioNTech SE's Stock Price Today?
A single share of BNTX can be purchased today for 87.21 -
What Is BioNTech SE’s Stock Symbol?
BioNTech SE trades on the nasdaq under the ticker symbol: BNTX -
When Is BioNTech SE’s Next Earnings Date?
The next quarterly earnings date for BioNTech SE is scheduled on May 6, 2024 -
When Is BNTX's next ex-dividend date?
BioNTech SE's next ex-dividend date is June 2, 2022 -
How To Buy BioNTech SE Stock?
You can buy BioNTech SE shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioNTech SE Competitors
-
Who Are BioNTech SE's Competitors?
Below is a list of companies who compete with BioNTech SE or are related in some way:
BioNTech SE Dividend Yield
Data Unavailable
BioNTech SE Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -78.5% | -22.27% |
| Revenue: | -63.59% | -19.76% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 8 |
| Sell Recommendations: | 1 |
| Price Target: | 113.52 |
| Upside from Last Price: | 30.17% |